ER
GMED icon

Enlightenment Research’s Globus Medical GMED Stock Holding History

Enlightenment Research’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$22K – 329
2018
Q4 		$22K Buy
+500
New +$24.9K 0.03% 433

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Enlightenment Research's GMED Position: Q1 2019 in Review

Enlightenment Research sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 500 shares — an estimated $22K sold.

Enlightenment Research first reported a position in GMED in Q4 2018 and held it in 1 quarter. The position peaked at $22K in Q4 2018. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

  • Enlightenment Research reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 500 Globus Medical shares in Q1 2019, an estimated $22K.
  • Enlightenment Research first reported a position in Globus Medical in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's Globus Medical position peaked at $22K in Q4 2018.
  • 269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.